Prism Medico and Pharmacy Share Price
29.70+0.00 (+3.16%)
+72.98% past 1 Year
Prism Medico and Pharmacy Ltd is engaged in trading in goods and commodities.The company is presently engaged in investing in shares and other securities and other financing activities.
Corporate filings & documents
Announcements
Dear Sir/Madam Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Annual Report of the company for the Financial Year 2025-2026. You are requested to kindly take the same on record and oblige.Thanking You.
1 week agoDear Sir/Madam Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Annual Report of the company for the Financial Year 2025-2026. You are requested to kindly take the same on record and oblige.Thanking You.
1 week agoDear Sir/ Madam Please find attached herewith intimation of Record Date for the purpose of conducting the 24th Annual General Meeting of the company to be held for the financial year ended 31st March 2026. You are requested to take the same on record and oblige.Thanking you.
1 week agoDear Sir/ Madam Please find attached herewith intimation of Record Date for the purpose of conducting the 24th Annual General Meeting of the company to be held for the financial year ended 31st March 2026. You are requested to take the same on record and oblige.Thanking you.
1 week agoDear Sir/Madam Please find the attached intimation of book closure for the 24th Annual General Meeting to be held for the financial year ended 31st March 2026.You are requested to take the same on record and oblige.Thanking you.
1 week agoDear Sir/Madam Please find the attached intimation of book closure for the 24th Annual General Meeting to be held for the financial year ended 31st March 2026.You are requested to take the same on record and oblige.Thanking you.
1 week agoDear Sir/ Madam Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report of the company for the financial year ended on March 31 2026.You are required to kindly take the same on record and oblige.Thanking you.
1 week agoDear Sir/ Madam Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report of the company for the financial year ended on March 31 2026.You are required to kindly take the same on record and oblige.Thanking you.
1 week agoDear Sir/ Madam Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report of the company for the financial year ended on March 31 2026.You are required to kindly take the same on record and oblige.Thanking you.
1 week agoDear Sir/ Madam Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report of the company for the financial year ended on March 31 2026.You are required to kindly take the same on record and oblige.Thanking you.
1 week agoDear Sir/Madam The 24th Annual General Meeting of M/s. Prism Medico and Pharmacy is scheduled to be held on 19th September 2026 through VC/OAVM. The notice of the same is attached herewith.You are requested to kindly take the same on record and oblige.Thanking you.
1 week agoDear Sir/Madam The 24th Annual General Meeting of M/s. Prism Medico and Pharmacy is scheduled to be held on 19th September 2026 through VC/OAVM. The notice of the same is attached herewith.You are requested to kindly take the same on record and oblige.Thanking you.
1 week ago1. Considered & approved: (i) Directors Report for the F.Y. ended March 31 2026(ii) notice of 24th AGM to be held on September 19 2026 at 12:30 P.M. through VC/OAVM2. Fixed date for closure of Register of Members & Share Transfer Books from September 13 2026 to September 19 2026 for the purpose of AGM3. Fixed September 12 2026 as the cut-off date to record the entitlement of the shareholders to cast their votes electronically for the AGM4. Approved appointment of Mr. Mast Ram Chechi as scrutinizer to conduct e-voting process of AGM5. Considered & recommended: (i) re-appointment of M/s. Garg Mendiratta and Associates Chartered Accountants as the Statutory Auditors of the company(ii) appointment of M/s. SDK & Associates Practicing Company Secretaries as the Secretarial Auditors of the Company(iii) to invest the funds of the company(iv) variation in objects of the Preferential Issue & in utilisation of the proceeds thereof as approved in the EOGM held on March 20 2026
1 week ago1. Considered & approved: (i) Directors Report for the F.Y. ended March 31 2026(ii) notice of 24th AGM to be held on September 19 2026 at 12:30 P.M. through VC/OAVM2. Fixed date for closure of Register of Members & Share Transfer Books from September 13 2026 to September 19 2026 for the purpose of AGM3. Fixed September 12 2026 as the cut-off date to record the entitlement of the shareholders to cast their votes electronically for the AGM4. Approved appointment of Mr. Mast Ram Chechi as scrutinizer to conduct e-voting process of AGM5. Considered & recommended: (i) re-appointment of M/s. Garg Mendiratta and Associates Chartered Accountants as the Statutory Auditors of the company(ii) appointment of M/s. SDK & Associates Practicing Company Secretaries as the Secretarial Auditors of the Company(iii) to invest the funds of the company(iv) variation in objects of the Preferential Issue & in utilisation of the proceeds thereof as approved in the EOGM held on March 20 2026
1 week agoPrism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2026 inter alia to consider and approve ? To consider and approve the Directors Report along with all necessary annexures thereof for the Financial Year ended March 31 2026;? To consider and fix day date time for holding the 24th Annual General Meeting of the company and approve the notice of the same;? To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting;? To appoint scrutinizer to conduct e-voting and poll process of 24th Annual General Meeting of the company;? To consider and recommend the re-appointment of M/s. Garg Mendiratta and Associates Chartered Accountants as the statutory auditors of the company and fix their remuneration. ? To consider and recommend appointment of M/s. SDK & Associates Practicing Company Secretaries as the secretarial auditors of the Company for five financial years from FY 2026-2027 to FY 2030-2031.? To consider and discuss any other routine matter or business of the company.
2 weeks agoPrism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2026 inter alia to consider and approve ? To consider and approve the Directors Report along with all necessary annexures thereof for the Financial Year ended March 31 2026;? To consider and fix day date time for holding the 24th Annual General Meeting of the company and approve the notice of the same;? To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting;? To appoint scrutinizer to conduct e-voting and poll process of 24th Annual General Meeting of the company;? To consider and recommend the re-appointment of M/s. Garg Mendiratta and Associates Chartered Accountants as the statutory auditors of the company and fix their remuneration. ? To consider and recommend appointment of M/s. SDK & Associates Practicing Company Secretaries as the secretarial auditors of the Company for five financial years from FY 2026-2027 to FY 2030-2031.? To consider and discuss any other routine matter or business of the company.
2 weeks agoPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 12th August 2026) which commenced at 01:30 P.M. and concluded at 03:30 P.M. have inter alia approved the following:? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 30th June 2026 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.
3 weeks agoPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 12th August 2026) which commenced at 01:30 P.M. and concluded at 03:30 P.M. have inter alia approved the following:? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 30th June 2026 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.
3 weeks agoPrism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th June 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
4 weeks agoPrism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th June 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
4 weeks agoDear Sir/Madam This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. The website of the company is http://www.prismmedico.in.You are requested to kindly take the same on record and oblige.Thank you.
1 month agoDear Sir/Madam This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. The website of the company is http://www.prismmedico.in.You are requested to kindly take the same on record and oblige.Thank you.
1 month agoDear Sir/Madam Please find the attache statements of investor complaints for the quarter ended 30th June 2026. You are requested to kindly take the same on record and oblige. Thanking You.
1 month agoDear Sir/Madam Please find the attache statements of investor complaints for the quarter ended 30th June 2026. You are requested to kindly take the same on record and oblige. Thanking You.
1 month agoDear Sir/ Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find the attached certificate issued by Registrar and Share Transfer Agent (RTA) for the quarter ended on 30th June 2026. Kindly take the same on record and oblige.Thank you.
1 month agoDear Sir/ Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find the attached certificate issued by Registrar and Share Transfer Agent (RTA) for the quarter ended on 30th June 2026. Kindly take the same on record and oblige.Thank you.
1 month agoDear Sir/Madam Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the attached intimation for your reference and record.Thanking you.
1 month agoDear Sir/Madam Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the attached intimation for your reference and record.Thanking you.
1 month agoPursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR) please find the attached intimation letter.You are requested to Kindly take the same on record and oblige.
2 months agoPursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR) please find the attached intimation letter.You are requested to Kindly take the same on record and oblige.
2 months agoPursuant to Code of Conduct to regulate monitor and report trading by insiders (Code) and applicable SEBI Regulations please find the attached intimation letter that the trading window for dealing in securities of the company by insiders stands closed from July 1 2026 and will be re-opened 48 hours after the declaration of the financial results for the quarter ended June 30 2026. You are requested to kindly take the same on record and oblige.
2 months agoPursuant to Code of Conduct to regulate monitor and report trading by insiders (Code) and applicable SEBI Regulations please find the attached intimation letter that the trading window for dealing in securities of the company by insiders stands closed from July 1 2026 and will be re-opened 48 hours after the declaration of the financial results for the quarter ended June 30 2026. You are requested to kindly take the same on record and oblige.
2 months agoPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 28th May 2026) which commenced at 03:00 P.M. and concluded at 05:00 P.M. have inter alia approved the following:? The Board considered and approved the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months agoPrism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of - the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Thursday the 28 day of May 2026 at 03:00 P.M. inter alia to: - 2026 Consider approve and take-on record the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company.
3 months agoPrism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of - the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Thursday the 28 day of May 2026 at 03:00 P.M. inter alia to: - 2026 Consider approve and take-on record the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company.
3 months agoDear Sir / Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 11th May 2026) which commenced at 04:00 P.M. and concluded at 04:30 P.M. have inter alia approved the following:1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates Chartered Accountants as internal auditors of the company for the financial year 2025-2026.You are requested to kindly take the same on your record and acknowledge receipt.Thanking You.
3 months agoDear Sir / Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 11th May 2026) which commenced at 04:00 P.M. and concluded at 04:30 P.M. have inter alia approved the following:1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates Chartered Accountants as internal auditors of the company for the financial year 2025-2026.You are requested to kindly take the same on your record and acknowledge receipt.Thanking You.
3 months agoWith reference to the subject cited this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday May 05 2026 at the registered office of the Company the following were considered and approved: 1. Allotment of 75 00 000 (Seventy Five Lacs) Equity Shares of face value of ?10/- each at an issue price of ?10/- (Rupees Ten Only) per Equity Share and 50 00 000 (Fifty Lacs) Convertible Warrants on a preferential basis at an issue price of ?10/- (Rupees Ten Only) per Warrant Convertible Warrants on Preferential Basis in accordance with and pursuant to the special resolution passed by the Members of the Company at their Extra-ordinary General Meeting held on March 20 2026 and In-Principle Approval received from BSE Ltd (Stock Exchange where the shares of the Company are listed) on March 25 2026. The details of the allottees have been enclosed herewith.
4 months agoWith reference to the subject cited this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday May 05 2026 at the registered office of the Company the following were considered and approved: 1. Allotment of 75 00 000 (Seventy Five Lacs) Equity Shares of face value of ?10/- each at an issue price of ?10/- (Rupees Ten Only) per Equity Share and 50 00 000 (Fifty Lacs) Convertible Warrants on a preferential basis at an issue price of ?10/- (Rupees Ten Only) per Warrant Convertible Warrants on Preferential Basis in accordance with and pursuant to the special resolution passed by the Members of the Company at their Extra-ordinary General Meeting held on March 20 2026 and In-Principle Approval received from BSE Ltd (Stock Exchange where the shares of the Company are listed) on March 25 2026. The details of the allottees have been enclosed herewith.
4 months agoDear Sir/Madam Please find the attached confirmation regarding non-applicability of large corporate entity framework.You are requested to take the same on record and oblige. Thanks and Regards.
4 months agoDear Sir/Madam Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find the attached certificate from the RTA for the quarter ended 31st March 2026.You are requested to kindly take the same on record and oblige.Thankyou.
4 months agoDear Sir/Madam Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find the attached certificate from the RTA for the quarter ended 31st March 2026.You are requested to kindly take the same on record and oblige.Thankyou.
4 months agoDear Sir/Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find the attached certificate issued by RTA for the quarter ended 31st March 2026.You are requested to kindly take the same on record and oblige.Thanking you.
4 months agoDear Sir/ Madam Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached the intimation.Kindly take the same on record and oblige.Thanking you.
4 months agoDear Sir/Madam Pursuant to Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 please find attached the attached disclosure for your reference and record.Kindly take the same on record and oblige.Thanking you.
4 months agoDear Sir/Madam Pursuant to Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 please find attached the attached disclosure for your reference and record.Kindly take the same on record and oblige.Thanking you.
4 months agoDear Sir/Madam Please find the attached intimation under Regulation 57(5) of SEBI (LODR) Regulations 2015.You are requested to kindly take the same on record and acknowledge the receipt. Thanking You.
5 months agoDear Sir/Madam Please find the attached intimation under Regulation 57(4) of SEBI (LODR) Regulations 2015.Kindly take the same on record and oblige. Thanking You.
5 months agoDear Sir/Madam Pursuant to Code of Conduct to regulate monitor and report Trading by Insider ("Code") and applicable SEBI Regulations please find the attached intimation of closure of trading window. You are requested to take the same on record and oblige.Thanking You.
5 months agoDear Sir/Madam Pursuant to Code of Conduct to regulate monitor and report Trading by Insider ("Code") and applicable SEBI Regulations please find the attached intimation of closure of trading window. You are requested to take the same on record and oblige.Thanking You.
5 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Kala Amb Suketi Road Sirmour Himachal Pradesh PIN: 173030 Tel No: NULL Fax No: NULL Email: [email protected] Internet: www.prismmedico.in
Registrars
Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg Gala No 9 Shiv Shakti, Industrial Estate,Sitaram Mill Comp. J R Boricha Marg, Lower Parel [E] PIN: Tel No: +91 22 4134 3255/ +91 22 4134 3256 Fax No: NULL Email: [email protected] Internet: www.purvashare.com
Management
Sakshi Laller, Whole Time Director
Davender Singh, Non Executive Director
Dinesh Kumar, Non Executive Independent Director
Pardeep Kumar, Non Executive Independent Director
Sameer Gupta, Company Secretary & Compliance Officer
Details
BSE 512217
NSE NULL
ISIN INE730E01016